Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04867668 · ClinicalTrials.gov registry record · NA
Digital Media for Cancer Control (to Prevent Vaping and Smoking Behavior)
A NA study, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 2,800
- Enrollment target
NCT04867668: Completed NA study, sponsored by George Washington University.
NCT04867668 is a NA study that has completed, run by George Washington University. The registered enrollment target is 2,800 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04867668, a NA study, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,800 participants
- Enrollment target
Study Summary
There is little published data on exposure to and evaluations of large-scale, online tobacco control campaigns. This project addresses the gap. Under 2 specific aims, the investigators will identify the independent effects of varying levels of digital message exposure to promote anti-tobacco attitudes, beliefs, or behaviors among youth and young adults, first through a randomized experiment online, and second through a field-based evaluation. These studies will advance the science of digital health and have wide application to future campaigns.
Primary Outcome
Frequency of vaping during the past 30 days
Interventions
- BEHAVIORAL Anti-vaping and anti-smoking digital advertising
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,800 participants |
| Start Date | 2021-02-20 |
| Est. Completion | 2026-02-28 |
| Phase | NA |
What the finished NCT04867668 record still lists
NCT04867668 is an interventional study that assigns participants to a tested intervention. Its 2,800 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% higher).
The record links to 0 conditions, and to 1 intervention - of which Anti-vaping and anti-smoking digital advertising is the first listed.
NCT04867668 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04867668 about?
NCT04867668 is a clinical study titled "Digital Media for Cancer Control (to Prevent Vaping and Smoking Behavior)". There is little published data on exposure to and evaluations of large-scale, online tobacco control campaigns. This project addresses the gap. Under 2 specific aims, the investigators will identify the independent effects of varying levels of digital message exposure to promote anti-tobacco attitud...
What is the current status of trial NCT04867668?
This trial is currently completed. It is a NA study. The enrollment target is 2,800 participants. The study started on 2021-02-20. Estimated completion is 2026-02-28.
What interventions are being tested in trial NCT04867668?
The interventions under investigation include: Anti-vaping and anti-smoking digital advertising (BEHAVIORAL).
Who is sponsoring clinical trial NCT04867668?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04867668's enrollment target sits among peer trials
2,800 43rd of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
- NCT05899439 · 2,800 participants
Immune Function and the Progression to T1D
- NCT06089109 · 2,800 participants · NA
Creating VIP Corps to Reduce Maternal Deaths
- NCT06345339 · 2,800 participants · Phase 2
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI